These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 38188583)

  • 1. Clinical trials for Chagas disease: etiological and pathophysiological treatment.
    Gonzaga BMS; Ferreira RR; Coelho LL; Carvalho ACC; Garzoni LR; Araujo-Jorge TC
    Front Microbiol; 2023; 14():1295017. PubMed ID: 38188583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental Combination Therapy with Amiodarone and Low-Dose Benznidazole in a Mouse Model of Trypanosoma cruzi Acute Infection.
    Barbosa JMC; Pedra Rezende Y; de Melo TG; de Oliveira G; Cascabulho CM; Pereira ENGDS; Daliry A; Salem KS
    Microbiol Spectr; 2022 Feb; 10(1):e0185221. PubMed ID: 35138142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis).
    Castro JA; de Mecca MM; Bartel LC
    Hum Exp Toxicol; 2006 Aug; 25(8):471-9. PubMed ID: 16937919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Approaches for the Treatment of Chagas Disease.
    Pandey RP; Nascimento MS; Moore CE; Raj VS; Kalil J; Cunha-Neto E
    Curr Drug Targets; 2021; 22(7):835-841. PubMed ID: 33238855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benznidazole and amiodarone combined treatment attenuates cytoskeletal damage in
    Barbosa JMC; Pedra-Rezende Y; Pereira LD; de Melo TG; Barbosa HS; Lannes-Vieira J; de Castro SL; Daliry A; Salomão K
    Front Cell Infect Microbiol; 2022; 12():975931. PubMed ID: 36093188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current trends in the pharmacological management of Chagas disease.
    Ribeiro V; Dias N; Paiva T; Hagström-Bex L; Nitz N; Pratesi R; Hecht M
    Int J Parasitol Drugs Drug Resist; 2020 Apr; 12():7-17. PubMed ID: 31862616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chagas Disease Chemotherapy: What Do We Know So Far?
    Zuma AA; de Souza W
    Curr Pharm Des; 2021; 27(38):3963-3995. PubMed ID: 33593251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benznidazole, itraconazole and their combination in the treatment of acute experimental chagas disease in dogs.
    Cunha ELA; Torchelsen FKVDS; Cunha LM; de Oliveira MT; Fonseca KDS; Vieira PMA; Carneiro CM; de Lana M
    Exp Parasitol; 2019 Sep; 204():107711. PubMed ID: 31254494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of pharmacological options for the treatment of Chagas disease.
    Lascano F; García Bournissen F; Altcheh J
    Br J Clin Pharmacol; 2022 Feb; 88(2):383-402. PubMed ID: 33314266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis and treatment of Chagas disease].
    Murcia L; Carrilero B; Saura D; Iborra MA; Segovia M
    Enferm Infecc Microbiol Clin; 2013 Feb; 31 Suppl 1():26-34. PubMed ID: 23453228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current prospects of specific treatment of Chagas' disease].
    Coura JR
    Bol Chil Parasitol; 1996; 51(3-4):69-75. PubMed ID: 9302778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Chagas Disease in the United States.
    Meymandi S; Hernandez S; Park S; Sanchez DR; Forsyth C
    Curr Treat Options Infect Dis; 2018; 10(3):373-388. PubMed ID: 30220883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination Therapy Using Benznidazole and Aspirin during the Acute Phase of Experimental Chagas Disease Prevents Cardiovascular Dysfunction and Decreases Typical Cardiac Lesions in the Chronic Phase.
    Pereira RS; Malvezi AD; Lovo-Martins MI; Lucchetti BFC; Santos JP; Tavares ER; Verri WA; de Almeida Araújo EJ; Yamauchi LM; Yamada-Ogatta SF; Martins-Pinge MC; Pinge-Filho P
    Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32366719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxic effects of nifurtimox and benznidazole, two drugs used against American trypanosomiasis (Chagas' disease).
    Castro JA; Diaz de Toranzo EG
    Biomed Environ Sci; 1988 Jun; 1(1):19-33. PubMed ID: 3151755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unveiling Lovastatin's Anti-Inflammatory Potential in Mouse's Brain during Acute
    Gonzaga BMS; Nisimura LM; Coelho LL; Ferreira RR; Horita SIM; Beghini DG; Estato V; Araújo-Jorge TC; Garzoni LR
    Biology (Basel); 2024 Apr; 13(5):. PubMed ID: 38785783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repurposing strategies for Chagas disease therapy: the effect of imatinib and derivatives against Trypanosoma cruzi.
    Simões-Silva MR; De Araújo JS; Peres RB; Da Silva PB; Batista MM; De Azevedo LD; Bastos MM; Bahia MT; Boechat N; Soeiro MNC
    Parasitology; 2019 Jul; 146(8):1006-1012. PubMed ID: 30859917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of Chagas disease chemotherapy.
    Guedes PM; Silva GK; Gutierrez FR; Silva JS
    Expert Rev Anti Infect Ther; 2011 May; 9(5):609-20. PubMed ID: 21609270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of nucleic acid amplification assays in monitoring treatment response in chagas disease: Usefulness in clinical trials.
    Sulleiro E; Muñoz-Calderon A; Schijman AG
    Acta Trop; 2019 Nov; 199():105120. PubMed ID: 31376368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chagas disease: Present status of pathogenic mechanisms and chemotherapy.
    Maya JD; Orellana M; Ferreira J; Kemmerling U; López-Muñoz R; Morello A
    Biol Res; 2010; 43(3):323-31. PubMed ID: 21249304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.